Tumor Markers: A Guide to Laboratory Testing
Tumor markers are substances found in blood, urine, or tissue that can be elevated in some cancers. They are useful in specific situations, but they have important limitations: many non-cancerous conditions raise them, and not every cancer produces them. This guide explains how tumor marker tests work, when they are typically ordered, and how to interpret results in context.
Key takeaways
- Tumor markers are substances that may be produced by cancer cells or by normal cells in response to cancer.
- A single tumor marker test cannot diagnose or rule out cancer on its own.
- Tumor markers are most useful for monitoring known disease, assessing response to treatment, and detecting recurrence.
- Some tumor markers are used with imaging and biopsy to help evaluate a specific suspected cancer.
- Benign conditions, inflammation, and other factors can cause elevated tumor marker levels.
What Are Tumor Markers?
Tumor markers are biological substances that can be detected in blood, urine, stool, or tumor tissue. They may be produced directly by cancer cells or by other cells in the body in response to a cancer. Common examples include proteins, hormones, enzymes, and genetic material. Because these substances can also arise from non-cancerous tissue, a tumor marker result is a piece of information rather than a diagnosis.
Laboratories measure tumor markers using techniques such as immunoassays, which detect specific proteins with antibodies, or molecular methods that identify DNA or RNA sequences. Each test has its own reference range, and results are reported as a number or as positive or negative. Reference ranges vary by laboratory, so results should always be interpreted using the range provided by the testing lab and in the context of the individual's health.
How Tumor Markers Are Used in Clinical Care
Tumor markers are rarely used alone to screen for cancer in people without symptoms. Instead, they are most often used after a cancer diagnosis to help monitor treatment response, detect recurrence, or guide therapy. For example, a marker that was elevated before treatment may be measured periodically; a falling level can suggest the treatment is working, while a rising level may prompt further evaluation.
In some situations, tumor markers are used alongside imaging and biopsy when a specific cancer is suspected. For instance, a marker may support a diagnosis when combined with other findings, but a tissue biopsy remains the standard for confirming cancer. Some markers are also used to help determine whether a targeted therapy is appropriate, which is a growing area of precision medicine.
Common Tumor Markers and What They Measure
Several tumor markers are widely known. CA-125 is often measured in people with suspected or known ovarian cancer, though it can also be elevated by endometriosis, pregnancy, and other benign conditions. PSA (prostate-specific antigen) is used to screen for and monitor prostate cancer, but it can rise with benign prostatic enlargement or infection. CEA is associated with colorectal and other cancers but is also elevated in smokers and people with liver or inflammatory conditions.
Other examples include AFP (alpha-fetoprotein), used in liver cancer and certain germ cell tumors; CA 19-9, associated with pancreatic and other gastrointestinal cancers; and hCG (human chorionic gonadotropin), used in gestational trophoblastic disease and some germ cell tumors. Each marker has a distinct pattern of elevation and a specific set of situations where it is clinically useful. Knowing which marker applies to which cancer helps avoid unnecessary testing.
Limitations and How to Interpret Results
Tumor markers have significant limitations. Many cancers do not produce elevated levels of any known marker, so a normal result does not rule out cancer. Conversely, benign conditions such as infections, inflammation, liver disease, and kidney disease can raise marker levels. This means a single abnormal result is not proof of cancer, and a normal result is not proof of health.
Because of these limitations, tumor marker tests are best used in specific clinical contexts, often by specialists managing a known diagnosis. Results should be interpreted alongside medical history, physical examination, imaging, and biopsy when indicated. If a marker is elevated without a clear explanation, repeat testing or additional evaluation may be recommended. Patients should discuss any tumor marker result with a qualified healthcare provider rather than trying to interpret it in isolation.
Frequently Asked Questions
Can a tumor marker test diagnose cancer?
No. Tumor markers alone cannot diagnose cancer. A diagnosis generally requires a tissue biopsy and other clinical findings. Tumor markers are used to support or monitor a diagnosis, not to confirm it by themselves.
What does it mean if my tumor marker level is elevated?
An elevated level may be caused by cancer, but it can also result from benign conditions such as inflammation, infection, or organ disease. Your healthcare provider will consider your symptoms, history, and other tests to determine what the result means.
Are tumor markers used for cancer screening?
In general, tumor markers are not recommended for routine cancer screening in people without symptoms, because they can produce false positives and false negatives. A few markers, such as PSA, are used in shared decision-making for specific populations.
Can tumor markers be normal if I have cancer?
Yes. Many cancers do not produce elevated levels of known tumor markers. A normal tumor marker result does not rule out cancer, and it should not replace other evaluations when cancer is suspected.
Sources
Ready to get tested? Compare markers, check any fasting guidance, then secure the panel via the BloodTestPanels partner at your convenience.
Order Alpha-Fetoprotein (AFP) Tumor Marker TestReviewed by the BloodTestPanels Editorial Team
The BloodTestPanels editorial team reviews laboratory panels against published reference material before publication.